Guggenheim Capital LLC Innoviva, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 32,606 shares of INVA stock, worth $580,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,606

Previous 81,255 59.87%

Holding current value

$580,060

Previous $1.33 Million 52.78%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$16.33 - $20.04 $794,438 - $974,925	-48,649 Reduced 59.87%	32,606 $629,000
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $562,147 - $640,223	39,038 Added 92.47%	81,255 $1.33 Million
Q1 2024 May 14, 2024	SELL	$14.56 - $16.78 $226,728 - $261,298	-15,572 Reduced 26.95%	42,217 $643,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $352,401 - $465,387	-28,604 Reduced 33.11%	57,789 $926,000
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $177,150 - $198,918	14,321 Added 19.87%	86,393 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $277,699 - $334,507	24,381 Added 51.12%	72,072 $917,000
Q1 2023 May 10, 2023	BUY	$10.73 - $13.6 $24,400 - $30,926	2,274 Added 5.01%	47,691 $536,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $3,138 - $3,665	266 Added 0.59%	45,417 $601,000
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $331,848 - $435,033	-28,583 Reduced 38.77%	45,151 $524,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $15,995 - $22,205	-1,117 Reduced 1.49%	73,734 $1.09 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $209,057 - $275,076	-13,584 Reduced 15.36%	74,851 $1.45 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $655,269 - $771,001	-41,186 Reduced 31.77%	88,435 $1.53 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $788,719 - $1.04 Million	60,392 Added 87.24%	129,621 $2.17 Million
Q2 2021 Aug 13, 2021	BUY	$11.45 - $13.96 $23,873 - $29,106	2,085 Added 3.11%	69,229 $928,000
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $312,223 - $363,320	-28,230 Reduced 29.6%	67,144 $802,000
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $460,827 - $616,412	49,392 Added 107.42%	95,374 $1.18 Million
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $53,561 - $75,130	-5,185 Reduced 10.13%	45,982 $481,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $91,138 - $121,042	7,932 Added 18.35%	51,167 $715,000
Q1 2020 Jun 02, 2020	SELL	$8.11 - $15.23 $277,686 - $521,475	-34,240 Reduced 44.19%	43,235 $508,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $44,193 - $61,819	-4,299 Reduced 5.26%	77,475 $1.1 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $8,854 - $12,818	-881 Reduced 1.07%	81,774 $862,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $11,960 - $13,649	913 Added 1.12%	82,655 $1.2 Million
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $320,920 - $470,246	-23,442 Reduced 22.29%	81,742 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $1.58 Million - $2.07 Million	-113,492 Reduced 51.9%	105,184 $1.84 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $1.57 Million - $1.81 Million	115,500 Added 111.94%	218,676 $3.33 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $2.79 Million - $3.65 Million	-207,321 Reduced 66.77%	103,176 $1.42 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $32,250 - $39,705	2,337 Added 0.76%	310,497 $5.18 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $1.02 Million - $1.28 Million	87,101 Added 39.4%	308,160 $4.37 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $2.67 Million - $3.12 Million	221,059	221,059 $3.12 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Innoviva, Inc. Transaction History